Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol. 2002;89:1120 3. 541. Bathina MN, Mickelsen S, Brooks C, et al. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol. 1998;82:589 93. 542. Meissner A, Stifoudi I, Weism ller P, et al. Sustained high quality of life in a 5-year long term follow-up after successful ablation for supra- ventricular tachycardia: results from a large retrospective patient cohort. Int J Med Sci. 2009;6:28 36. 543. Wood KA, Stewart AL, Drew BJ, et al. Patient perception of symptoms and quality of life following ablation in patients with supraventricular tachycardia. Heart Lung. 2010;39:12 20. 544. Yildirim O, Yontar OC, Semiz M, et al. The effect of radiofrequency ab- lation treatment on quality of life and anxiety in patients with supraven- tricular tachycardia. Eur Rev Med Pharmacol Sci. 2012;16:2108 12. 545. Farkowski MM, Pytkowski M, Maciag A, et al. Gender-related differ- ences in outcomes and resource utilization in patients undergoing radio- frequency ablation of supraventricular tachycardia: results from Patients Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace. 2014:1821 7. 546. Larson MS, McDonald K, Young C, et al. Quality of life before and after radiofrequency catheter ablation in patients with drug refractory atrioven- tricular nodal reentrant tachycardia. Am J Cardiol. 1999;84:471 3, A9. 547. Dewland TA, Glidden DV, Marcus GM. Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter. PLoS One. 2014;9:e100509. 